For investors seeking momentum, Schwab U.S. Dividend Equity ETF (SCHD) is probably on radar now. The fund just hit a 52-week high and is up about 30.7% from its 52-week low price of $44.03/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
SCHD in Focus
SCHD provides exposure to dividend yielding U.S. stocks issued by companies with a record of consistent dividend payments. It has key holdings in consumer staples, information technology, industrials and consumer discretionary. The fund charges 6 basis points in annual fees (see: all the Large Cap Value ETFs here).
Why the Move?
The dividend corner of the broad U.S. stock market has been an area to watch out for lately, given the uncertainty related to the initial level U.S.-China trade deal. This has raised the appeal for dividend investing. This is because dividend products offer the best combination of safety in the form of payouts and stability as these are less immune to large swings in stock prices.
More Gains Ahead?
Currently, SCHD has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. The fund has a positive weighted alpha of 18.60. So, there is definitely still some promise for those who want to ride on this surging ETF a little longer, especially if uncertainty remains in the market.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, Schwab U.S. Dividend Equity ETF (SCHD) is probably on radar now. The fund just hit a 52-week high and is up about 30.7% from its 52-week low price of $44.03/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
SCHD in Focus
SCHD provides exposure to dividend yielding U.S. stocks issued by companies with a record of consistent dividend payments. It has key holdings in consumer staples, information technology, industrials and consumer discretionary. The fund charges 6 basis points in annual fees (see: all the Large Cap Value ETFs here).
Why the Move?
The dividend corner of the broad U.S. stock market has been an area to watch out for lately, given the uncertainty related to the initial level U.S.-China trade deal. This has raised the appeal for dividend investing. This is because dividend products offer the best combination of safety in the form of payouts and stability as these are less immune to large swings in stock prices.
More Gains Ahead?
Currently, SCHD has a Zacks ETF Rank #3 (Hold) with a Medium risk outlook. Therefore, it is hard to get a handle on its future returns one way or the other. The fund has a positive weighted alpha of 18.60. So, there is definitely still some promise for those who want to ride on this surging ETF a little longer, especially if uncertainty remains in the market.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on SCHD - FREE